The relationship between the early-life gastrointestinal microbiome and childhood nocturnal cough

Amy A Eapen1, Tengfei Ma2, Alexandra R Sitarik3

  • 1Department of Internal Medicine, Division of Allergy and Clinical Immunology, Henry Ford Health, Detroit, Mich; Department of Public Health Sciences, Henry Ford Health, Detroit, Mich.

Insights

The early gut microbiome in infants is linked to nocturnal cough, with specific microbial differences observed in children who develop asthma. These findings suggest the gut microbiome may aid in identifying children at risk for persistent cough.

Area of Science:

  • Pediatric Health
  • Microbiome Research
  • Respiratory Medicine

Background:

  • Nocturnal cough affects a third of children and is often linked to asthma.
  • The relationship between the gut microbiome and nocturnal cough in children is not well understood.

Purpose of the Study:

  • To investigate the association between early-life gut microbiome composition and nocturnal cough.
  • To examine this association in the context of childhood asthma.

Main Methods:

  • Analyzed gut microbiota from 512 children at 1 and 6 months using 16S rRNA sequencing.
  • Assessed nocturnal cough and asthma diagnosis at age 4 years.
  • Employed microbiome regression-based kernel association tests (MiRKAT) and negative binomial regression.

Main Results:

  • Infant gut microbial composition differences were associated with nocturnal cough (P = .045).
  • 78 operational taxonomic units (OTUs) significantly correlated with nocturnal cough overall.
  • 110 OTUs showed significant interaction with asthma status, with Lachnospiraceae genera Blautia and Dorea being predominant.

Conclusions:

  • Infantile gut microbiome development is associated with nocturnal cough and asthma status by age 4.
  • Further research is warranted to explore the gut microbiome's role in early identification of children at risk for nocturnal cough.
  • The gut microbiome may offer insights for predicting cough risk, with or without asthma.
Abstract

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
71.3K
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
282
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
70.5K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
230
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
54
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205